Patents Assigned to ABSOS, LLC
  • Anti-CD47 antibodies
    Patent number: 11352425
    Abstract: The present invention provides anti-CD47 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic and diagnostic methods for the treatment of cancer, ischemic-reperfusion injury, and other diseases.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: June 7, 2022
    Assignee: ABSOS, LLC
    Inventors: John Lippincott, Dana Duey, Larry Green